Cellectar Biosciences Partners with Evestia Clinical for Phase 1b Trial of CLR 125 in Triple-Negative Breast Cancer Read more
FDA Grants Priority Review to AstraZeneca and Daiichi Sankyo’s Enhertu for First-Line HER2-Positive Metastatic Breast Cancer Read more
Sanofi Boosts Sanofi Ventures with $625M to Accelerate Biotech and Digital Health Investments Read more